Sponsored By
PlasticsToday Staff

March 16, 2016

1 Min Read
Drug-free pain-relief device wins Wearable Tech category at SXSW

A wearable device developed by NeuroMetrix Inc. (Waltham, MA) to treat a range of chronic pain conditions took first place at the 19th annual SXSW Interactive Innovation Awards in Austin, TX, last night. Quell was recognized for its breakthrough technology by going beyond traditional wearables that only offer tracking to truly improving the quality of life for its users, said the company in a news release announcing the award.

Quell was launched in June 2015. In a recent clinical study cited by the company, 81% of participants reported reduced pain using the device and 67% reported a reduction in pain medication use after 60 days.

Worn just below the knee, the patented OptiTherapy technology in Quell delivers customizable, 100% drug-free chronic pain relief to wearers, without a prescription. It is the only over-the-counter chronic pain wearable that has been FDA cleared for use while sleeping.

An updated version of Quell became available earlier this month, which gives users the option to control their therapy discreetly via mobile app.

Founded in 1996, NeuroMetrix was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like